A Retrospective Study of First-Line Immunotherapy for Advanced Non-Small Cell Lung Cancer in the Elderly
{{output}}
Objectives: In this study, we compared the efficacy and safety of first-line IO among different age subgroups of elderly patients, as well as in comparison to non-elderly patients with advanced NSCLC. Additionally, we investigate... ...
